Hear it from our customers
“Cellbyte consolidates complex HTA data in a structured way, enabling users to find insights in just a few clicks. Its AI analyzes multiple analogs simultaneously, examining study designs, outcomes, and rationales, which can now be completed in few minutes instead of hours. The platform also ensures reliability by linking each insight directly to its original source. ”
“HAS documentation used to mean reading TC opinions and hearing transcripts line by line. With Cellbyte I can interrogate them directly - surfacing the committee's reasoning, the questions raised in the hearing, and how they shaped the final rating, with every point traceable to the original text.”
Assessing the impact of
biomarker status on benefit
ratings and evidence confirmation
Assess whether biomarker-based oncology therapies are rated differently by the G-BA, and whether orphan status offsets the difference. No database classifies AMNOG procedures by biomarker status - by hand, a 8-week manual extraction across 521 procedures.
Cellbyte classified every G-BA oncology assessment by biomarker status from its indication wording. It merged benefit rating and orphan designation onto each procedure, with passage-level citations.
From each procedure’s documents, it also extracted whether the manufacturer’s evidence was judged sufficient to support the benefit rating. It then mapped these classifications to negotiated prices and patient populations to size the financial impact of biomarker status.
8 weeks → 2 weeks
Assessing the impact of OS length on benefit rating and pricing outcomes
Assess how the OS delta between an assessed product and its trial comparator affects benefit rating and price. Previously, answering took a three-week analyst sprint through 150+ page documents.
Cellbyte surfaced every G-BA oncology assessment with each product's benefit rating and launch price. It extracted the OS difference from each dossier, with passage-level citations.
3 weeks → 8 hours
A decade of OS deltas, mapped to ratings and negotiated prices, delivered as a referenced Excel in a single working day. 93% less research time.
“Cellbyte saved me so much time. I can quickly check the sources and the specific passage where the AI found certain information.”